Goldman Sachs Maintains Neutral on Chemours, Lowers Price Target to $23
Portfolio Pulse from Benzinga Newsdesk
Goldman Sachs analyst Duffy Fischer maintains a Neutral rating on Chemours (NYSE:CC) and lowers the price target from $29 to $23.

September 03, 2024 | 1:34 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Goldman Sachs has maintained a Neutral rating on Chemours and reduced the price target from $29 to $23, indicating a less optimistic outlook.
The reduction in price target from $29 to $23 by Goldman Sachs suggests a less favorable view on Chemours' future performance, which could lead to a negative short-term impact on its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100